UnitedHealth Group has announced a deal to acquire Catamaran Corporation for $12.8 billion which would improve their market position in benefits management segment and add to their negotiating power with drug makers. The pharmacy benefits segment has been in focus as the drug companies are pushed for discounting their high-priced treatment options.
UnitedHealth Group Inc. will pay $61.5 per share for Catamaran Corporation, nearly 27 percent premium to Catamaran’s closing price of $48.3 on Friday. Catamaran stock jumped 24 percent to close at $59.83 after the deal was announced. UnitedHealth will finance the deal with a mix of cash and debt.
00:02 AT&T Aims for an Empire in Merger Talks With Time Warner1
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T
12:55 McDonald's shares pop as investors cheer third-quarter beat
11:10 Merged BAT-Reynolds could be loaded with up to $55 billion of debt, analysts say